Cogent Biosciences, Inc. (COGT)
34.41
-0.59
(-1.69%)
USD |
NASDAQ |
Sep 01, 14:54
Cogent Biosciences Total Long Term Debt (Quarterly) : 242.77M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 242.77M |
| March 31, 2026 | 237.27M |
| December 31, 2025 | 237.25M |
| September 30, 2025 | 58.85M |
| June 30, 2025 | 59.00M |
| March 31, 2025 | 15.48M |
| December 31, 2024 | 15.90M |
| September 30, 2024 | 16.31M |
| June 30, 2024 | 16.71M |
| March 31, 2024 | 17.09M |
| December 31, 2023 | 17.47M |
| September 30, 2023 | 17.83M |
| June 30, 2023 | 18.18M |
| March 31, 2023 | 18.52M |
| December 31, 2022 | 18.23M |
| September 30, 2022 | 18.07M |
| June 30, 2022 | 19.01M |
| March 31, 2022 | 1.127M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.831M |
| September 30, 2021 | 1.438M |
| June 30, 2021 | 2.031M |
| March 31, 2021 | 2.605M |
| December 31, 2020 | 3.155M |
| September 30, 2020 | 141.92M |
| June 30, 2020 | 3.545M |
| March 31, 2020 | 3.987M |
| December 31, 2019 | 4.413M |
| September 30, 2019 | 4.831M |
| June 30, 2019 | 5.243M |
| March 31, 2019 | 5.645M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | 103.70M |
| Erasca, Inc. | 39.27M |
| Moderna, Inc. | 1.266B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |